BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2050319)

  • 1. Prospective, randomized controlled trial of interferon-alpha in children with chronic hepatitis B.
    Ruiz-Moreno M; Rua MJ; Molina J; Moraleda G; Moreno A; García-Aguado J; Carreño V
    Hepatology; 1991 Jun; 13(6):1035-9. PubMed ID: 2050319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A controlled study of treatment with recombinant interferon alpha of chronic hepatitis due to the B virus in childhood].
    Carreño V; Porres JC; Ruiz-Moreno M; Gutiez J; Bartolomé FJ
    Rev Esp Enferm Dig; 1991 Jan; 79(1):24-8. PubMed ID: 2031770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial.
    Mutchnick MG; Appelman HD; Chung HT; Aragona E; Gupta TP; Cummings GD; Waggoner JG; Hoofnagle JH; Shafritz DA
    Hepatology; 1991 Sep; 14(3):409-15. PubMed ID: 1874487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with interferon gamma versus interferons alfa and gamma in children with chronic hepatitis B.
    Ruiz-Moreno M; Rúa MJ; Moraleda G; Guardia L; Moreno A; Carreño V
    Pediatrics; 1992 Aug; 90(2 Pt 1):254-8. PubMed ID: 1641292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of a 12-month course of recombinant human interferon-alpha in chronic delta (type D) hepatitis: a multicenter Italian study.
    Rosina F; Pintus C; Meschievitz C; Rizzetto M
    Hepatology; 1991 Jun; 13(6):1052-6. PubMed ID: 2050321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphoblastoid interferon alfa with or without steroid pretreatment in children with chronic hepatitis B: a multicenter controlled trial.
    Gregorio GV; Jara P; Hierro L; Diaz C; de la Vega A; Vegnente A; Iorio R; Bortolotti F; Crivellaro C; Zancan L; Daniels H; Portmann B; Mieli-Vergani G
    Hepatology; 1996 Apr; 23(4):700-7. PubMed ID: 8666320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon treatment of anti-HBe positive and HBV DNA positive chronic hepatitis B.
    Alberti A; Fattovich G; Pontisso P; Brollo L; Belussi F; Ruol A
    Chemioterapia; 1988 Dec; 7 Suppl 3():15-9. PubMed ID: 3073869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy for chronic viral hepatitis.
    Alvarez F
    Clin Invest Med; 1996 Oct; 19(5):381-8. PubMed ID: 8889278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levamisole and interferon in children with chronic hepatitis B.
    Ruiz-Moreno M; García R; Rua MJ; Serrano B; Moraleda G; Feijoo E; Bartolomé J; Ortiz F; Castillo I; Carreño V
    Hepatology; 1993 Aug; 18(2):264-9. PubMed ID: 7687978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose interferon results in high HBsAg seroclearance in children with chronic hepatitis B infection.
    Ertem D; Acar Y; Kotiloğlu Karaa E; Pehlivanoğlu E
    Turk J Pediatr; 2003; 45(2):123-8. PubMed ID: 12921298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
    Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
    Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon vs. adenine arabinoside 5'-monophosphate in patients with anti-HBe-positive chronic hepatitis.
    Buti M; Jardi R; Rodriguez-Frias F; Allende H; Cotrina M; Esteban R; Guardia J
    J Med Virol; 1996 Aug; 49(4):325-8. PubMed ID: 8877766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
    Ruiz Moreno M; Jimenez J; Porres JC; Bartolomé J; Moreno A; Carreño V
    Digestion; 1990; 45(1):26-33. PubMed ID: 2187723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
    Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
    Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High rate of mutations in the hepatitis B core gene during the immune clearance phase of chronic hepatitis B virus infection.
    Bozkaya H; Ayola B; Lok AS
    Hepatology; 1996 Jul; 24(1):32-7. PubMed ID: 8707278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of different combination therapies for children with HBeAg positive chronic hepatitis B].
    Zhong XH; Deng X; Chen XC; Zhou BP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):62-3. PubMed ID: 17429539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.